REPORT ID 953

Global Herceptin Biosimilar Market Professional Survey Report 2017

Publish Date
04-Dec-17
Pages
107
Format
Electronic (PDF)

This report studies Herceptin Biosimilar in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
    Mylan
    Amgen
    Mabion
    AryoGen Biopharma
    Genor Biopharma
    The Instituto Vital Brazil
    Celltrion
    Gedeon Richter
    ...

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Capsule
    Tablet
    Others

By Application, the market can be split into
    Healthcare&Pharmaceuticals
    Others

By Regions, this report covers (we can add the regions/countries as you want)
    North America
    China
    Europe
    Southeast Asia
    Japan
    India

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Herceptin Biosimilar Market Professional Survey Report 2017
1 Industry Overview of Herceptin Biosimilar
    1.1 Definition and Specifications of Herceptin Biosimilar
        1.1.1 Definition of Herceptin Biosimilar
        1.1.2 Specifications of Herceptin Biosimilar
    1.2 Classification of Herceptin Biosimilar
        1.2.1 Capsule
        1.2.2 Tablet
        1.2.3 Others
    1.3 Applications of Herceptin Biosimilar
        1.3.1 Healthcare&Pharmaceuticals
        1.3.2 Others
        1.3.3 Application 3
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 China
        1.4.3 Europe
        1.4.4 Southeast Asia
        1.4.5 Japan
        1.4.6 India

2 Manufacturing Cost Structure Analysis of Herceptin Biosimilar
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of Herceptin Biosimilar
    2.3 Manufacturing Process Analysis of Herceptin Biosimilar
    2.4 Industry Chain Structure of Herceptin Biosimilar

3 Technical Data and Manufacturing Plants Analysis of Herceptin Biosimilar
    3.1 Capacity and Commercial Production Date of Global Herceptin Biosimilar Major Manufacturers in 2016
    3.2 Manufacturing Plants Distribution of Global Herceptin Biosimilar Major Manufacturers in 2016
    3.3 R&D Status and Technology Source of Global Herceptin Biosimilar Major Manufacturers in 2016
    3.4 Raw Materials Sources Analysis of Global Herceptin Biosimilar Major Manufacturers in 2016

4 Global Herceptin Biosimilar Overall Market Overview
    4.1 2012-2017E Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1 2012-2017E Global Herceptin Biosimilar Capacity and Growth Rate Analysis
        4.2.2 2016 Herceptin Biosimilar Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2012-2017E Global Herceptin Biosimilar Sales and Growth Rate Analysis
        4.3.2 2016 Herceptin Biosimilar Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2012-2017E Global Herceptin Biosimilar Sales Price
        4.4.2 2016 Herceptin Biosimilar Sales Price Analysis (Company Segment)

5 Herceptin Biosimilar Regional Market Analysis
    5.1 North America Herceptin Biosimilar Market Analysis
        5.1.1 North America Herceptin Biosimilar Market Overview
        5.1.2 North America 2012-2017E Herceptin Biosimilar Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America 2012-2017E Herceptin Biosimilar Sales Price Analysis
        5.1.4 North America 2016 Herceptin Biosimilar Market Share Analysis
    5.2 China Herceptin Biosimilar Market Analysis
        5.2.1 China Herceptin Biosimilar Market Overview
        5.2.2 China 2012-2017E Herceptin Biosimilar Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 China 2012-2017E Herceptin Biosimilar Sales Price Analysis
        5.2.4 China 2016 Herceptin Biosimilar Market Share Analysis
    5.3 Europe Herceptin Biosimilar Market Analysis
        5.3.1 Europe Herceptin Biosimilar Market Overview
        5.3.2 Europe 2012-2017E Herceptin Biosimilar Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 Europe 2012-2017E Herceptin Biosimilar Sales Price Analysis
        5.3.4 Europe 2016 Herceptin Biosimilar Market Share Analysis
    5.4 Southeast Asia Herceptin Biosimilar Market Analysis
        5.4.1 Southeast Asia Herceptin Biosimilar Market Overview
        5.4.2 Southeast Asia 2012-2017E Herceptin Biosimilar Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Southeast Asia 2012-2017E Herceptin Biosimilar Sales Price Analysis
        5.4.4 Southeast Asia 2016 Herceptin Biosimilar Market Share Analysis
    5.5 Japan Herceptin Biosimilar Market Analysis
        5.5.1 Japan Herceptin Biosimilar Market Overview
        5.5.2 Japan 2012-2017E Herceptin Biosimilar Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Japan 2012-2017E Herceptin Biosimilar Sales Price Analysis
        5.5.4 Japan 2016 Herceptin Biosimilar Market Share Analysis
    5.6 India Herceptin Biosimilar Market Analysis
        5.6.1 India Herceptin Biosimilar Market Overview
        5.6.2 India 2012-2017E Herceptin Biosimilar Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India 2012-2017E Herceptin Biosimilar Sales Price Analysis
        5.6.4 India 2016 Herceptin Biosimilar Market Share Analysis

6 Global 2012-2017E Herceptin Biosimilar Segment Market Analysis (by Type)
    6.1 Global 2012-2017E Herceptin Biosimilar Sales by Type
    6.2 Different Types of Herceptin Biosimilar Product Interview Price Analysis
    6.3 Different Types of Herceptin Biosimilar Product Driving Factors Analysis
        6.3.1 Capsule of Herceptin Biosimilar Growth Driving Factor Analysis
        6.3.2 Tablet of Herceptin Biosimilar Growth Driving Factor Analysis
        6.3.3 Others of Herceptin Biosimilar Growth Driving Factor Analysis

7 Global 2012-2017E Herceptin Biosimilar Segment Market Analysis (by Application)
    7.1 Global 2012-2017E Herceptin Biosimilar Consumption by Application
    7.2 Different Application of Herceptin Biosimilar Product Interview Price Analysis
    7.3 Different Application of Herceptin Biosimilar Product Driving Factors Analysis
        7.3.1 Healthcare&Pharmaceuticals of Herceptin Biosimilar Growth Driving Factor Analysis
        7.3.2 Others of Herceptin Biosimilar Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Herceptin Biosimilar
    8.1 Mylan
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Product A
            8.1.2.2 Product B
        8.1.3 Mylan 2016 Herceptin Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 Mylan 2016 Herceptin Biosimilar Business Region Distribution Analysis
    8.2 Amgen
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Product A
            8.2.2.2 Product B
        8.2.3 Amgen 2016 Herceptin Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 Amgen 2016 Herceptin Biosimilar Business Region Distribution Analysis
    8.3 Mabion
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Product A
            8.3.2.2 Product B
        8.3.3 Mabion 2016 Herceptin Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 Mabion 2016 Herceptin Biosimilar Business Region Distribution Analysis
    8.4 AryoGen Biopharma
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
            8.4.2.1 Product A
            8.4.2.2 Product B
        8.4.3 AryoGen Biopharma 2016 Herceptin Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 AryoGen Biopharma 2016 Herceptin Biosimilar Business Region Distribution Analysis
    8.5 Genor Biopharma
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
            8.5.2.1 Product A
            8.5.2.2 Product B
        8.5.3 Genor Biopharma 2016 Herceptin Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 Genor Biopharma 2016 Herceptin Biosimilar Business Region Distribution Analysis
    8.6 The Instituto Vital Brazil
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
            8.6.2.1 Product A
            8.6.2.2 Product B
        8.6.3 The Instituto Vital Brazil 2016 Herceptin Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 The Instituto Vital Brazil 2016 Herceptin Biosimilar Business Region Distribution Analysis
    8.7 Celltrion
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
            8.7.2.1 Product A
            8.7.2.2 Product B
        8.7.3 Celltrion 2016 Herceptin Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 Celltrion 2016 Herceptin Biosimilar Business Region Distribution Analysis
    8.8 Gedeon Richter
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
            8.8.2.1 Product A
            8.8.2.2 Product B
        8.8.3 Gedeon Richter 2016 Herceptin Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 Gedeon Richter 2016 Herceptin Biosimilar Business Region Distribution Analysis

9 Development Trend of Analysis of Herceptin Biosimilar Market
    9.1 Global Herceptin Biosimilar Market Trend Analysis
        9.1.1 Global 2017-2022 Herceptin Biosimilar Market Size (Volume and Value) Forecast
        9.1.2 Global 2017-2022 Herceptin Biosimilar Sales Price Forecast
    9.2 Herceptin Biosimilar Regional Market Trend
        9.2.1 North America 2017-2022 Herceptin Biosimilar Consumption Forecast
        9.2.2 China 2017-2022 Herceptin Biosimilar Consumption Forecast
        9.2.3 Europe 2017-2022 Herceptin Biosimilar Consumption Forecast
        9.2.4 Southeast Asia 2017-2022 Herceptin Biosimilar Consumption Forecast
        9.2.5 Japan 2017-2022 Herceptin Biosimilar Consumption Forecast
        9.2.6 India 2017-2022 Herceptin Biosimilar Consumption Forecast
    9.3 Herceptin Biosimilar Market Trend (Product Type)
    9.4 Herceptin Biosimilar Market Trend (Application)

10 Herceptin Biosimilar Marketing Type Analysis
    10.1 Herceptin Biosimilar Regional Marketing Type Analysis
    10.2 Herceptin Biosimilar International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of Herceptin Biosimilar by Region
    10.4 Herceptin Biosimilar Supply Chain Analysis

11 Consumers Analysis of Herceptin Biosimilar
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis

12 Conclusion of the Global Herceptin Biosimilar Market Professional Survey Report 2017
    Methodology
    Analyst Introduction
    Data Source